MedTrace Logo

Use of the Shang Ring Circumcision Device in Boys Below 18 Years Old in Kenya

NCT01891409 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2015-01-19

No results posted yet for this study

Summary

A proof of concept study to evaluate the feasibility of using the Shang Ring, a novel male circumcision device across all childhood age groups namely infants (under 1), 1-5 age group, 6-12 age group and the 13-17 age group. The study will evaluate the safety, efficacy and course of wound healing when using the Shang Ring technique across the four childhood age groups.

Conditions

  • Human Immunodeficiency Virus

Interventions

DEVICE

Male circumcision using the Shang Ring device

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    collaborator OTHER

  • Kenya National AIDS & STI Control Programme

    collaborator OTHER

  • Kenya Ministry of Health

    collaborator OTHER_GOV

  • EngenderHealth

    lead OTHER

Principal Investigators

  • Quentin Awori, MBChB, CPI · EngenderHealth

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Month
Max Age
17 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • Kenya

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01891409 on ClinicalTrials.gov